New Gut Microbiome Research Targets Portal Hypertension Dr David Johnson explores recent data with urolithin A, a gut metabolite that’s shown early promise in studies with portal hypertension.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback